Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized c (Q63916021)
Jump to navigation
Jump to search
scientific article published on 01 September 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized c |
scientific article published on 01 September 2005 |
Statements
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial (English)
Denis Marleau
Marcelo Cantarovich
Andre Roy
Eric M Yoshida
Paul J Marotta
Paul D Greig
Norman M Kneteman
Leslie B Lilly
Charles H Scudamore
Vincent G Bain
William J Wall
Jeffrey S T Barkun